External PhD candidate Erasmus School of Health Policy & Management Health Economics (HE)
- Location
- Burg. Oudlaan 50, Rotterdam
- rotteveel@eshpm.eur.nl
More information
‹ Back to overview
Profile
- Adriënne H. Rotteveel, Mattijs S. Lambooij, Joline J.A. van de Rijt, Job van Exel, Karel G.M. Moons & G. Ardine de Wit (2021) - What influences the outcome of active disinvestment processes in healthcare? A qualitative interview study on five recent cases of active disinvestment - BMC Health Services Research, 21 (1) - doi: 10.1186/s12913-021-06298-3
- Adrienne Rotteveel, MS (Mattijs) Lambooij, NPA Zuithoff, Job Exel, KGM (Karel) Moons & GA (Ardine) de Wit (2020) - Valuing healthcare goods and services: A systematic review and meta-analysis on the WTA-WTP disparity - Pharmacoeconomics (Print), 38, 443-458 - doi: 10.1007/s40273-020-00890-x
- Adriënne H. Rotteveel, Mattijs S. Lambooij, Joline J.A. van de Rijt, Job van Exel, Karel G.M. Moons & G. Ardine de Wit (2021) - What influences the outcome of active disinvestment processes in healthcare? A qualitative interview study on five recent cases of active disinvestment - BMC Health Services Research, 21 (1) - doi: 10.1186/s12913-021-06298-3
- Adrienne Rotteveel, MS (Mattijs) Lambooij, NPA Zuithoff, Job Exel, KGM (Karel) Moons & GA (Ardine) de Wit (2020) - Valuing healthcare goods and services: A systematic review and meta-analysis on the WTA-WTP disparity - Pharmacoeconomics (Print), 38, 443-458 - doi: 10.1007/s40273-020-00890-x
- Adriënne H. Rotteveel, Mattijs S. Lambooij, Joline J.A. van de Rijt, Job van Exel, Karel G.M. Moons & G. Ardine de Wit (2021) - What influences the outcome of active disinvestment processes in healthcare? A qualitative interview study on five recent cases of active disinvestment - BMC Health Services Research, 21 (1) - doi: 10.1186/s12913-021-06298-3
- Adrienne Rotteveel, MS (Mattijs) Lambooij, NPA Zuithoff, Job Exel, KGM (Karel) Moons & GA (Ardine) de Wit (2020) - Valuing healthcare goods and services: A systematic review and meta-analysis on the WTA-WTP disparity - Pharmacoeconomics (Print), 38, 443-458 - doi: 10.1007/s40273-020-00890-x